UFC middleweight Oskar Piechota is in hot water following a statement made by the United States Anti Doping Agency (USADA).
Overall, the statement detailed what Piechota tested positive for. In particular, the middleweight tested positive for a human growth hormone. Additionally, the news was first announced by the USADA officials after Piechota accepted a 22-month suspension.
USADA Statement On Oskar Piechota Failing Drug Test
Following Piechota’s acceptance of the terms, the agency released details of the situation.
“Piechota, 31, tested positive for growth hormone-releasing peptide 2 (GHRP-2 or pralmorelin) and GHRP-2 (1-3) free acid, a metabolite of GHRP-2, as the result of a urine sample collected on September 25, 2020,” USADA officials said in a statement. “GHRP-2 is a Specified Substance in the class of Peptide Hormones, Growth Factors, Related Substances, and Mimetics and is prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.”
Despite testing positive for a human growth hormone, Piechota did cooperate with USADA and thus his sentence was reduced.
“Piechota received a reduction to the default two-year sanction based on his Full and Complete Cooperation. His 22-month period of ineligibility began on September 25, 2020, the date his positive sample was collected.” The USADA statement read.
First and foremost, based on the information provided, Piechota will be able to return to action on Sept. 25, 2022. With some time off, the UFC athlete will have the chance to improve his game. Prior to this mishap, Piechota had a record of 2-3 in the UFC. While that isn’t the most sterling record, his fighting style has always been exciting. The 33-year old last competed against Marc Barriault last June, however, due to the positive test, the result has been overturned to a no-contest.
What do you make of the recent news about Oskar Piechota testing positive for a banned substance? Let us know below what you think!